España
Acceder
  1. Inicio
  2. Perfil de Thonn
  3. Participaciones

Participaciones del usuario Thonn

Thonn 22/07/22 11:05
Ha respondido al tema Novavax (NVAX): Un Nuevo Comienzo
Stan comenta que el precio ahora no es transparente porque es parte de un contrato multimillonario (el de OWS) que cubre la fabricación y algunas dosis.Comenta también que más adelante, primero formarán una estrategia de precios con el gobierno de USA y después, cuando se vuelva un producto comercial estándar entonces fijarán un precio adecuado, y es aquí donde comenta que el precio probablemente esté en el rango de otras vacunas, sobre los $30, pero que todavía no lo han decidido.Minuto 5:25 hasta 6:15https://youtu.be/_CKrYk_Glrk?t=323
Ir a respuesta
Thonn 22/07/22 06:22
Ha respondido al tema Novavax (NVAX): Un Nuevo Comienzo
Lo de las 5 millones a mí tampoco me cuadra. En la presentación de la CDC dijeron poco más de 1 millón.Con respecto a los 30$, no habla de circunstancias actuales sino de un futuro en el que la compra de vacunas ya no esté centralizada por el gobierno. 
Ir a respuesta
Thonn 21/07/22 12:45
Ha respondido al tema Novavax (NVAX): Un Nuevo Comienzo
 Safety and Immunogenicity of NVX-CoV2373 in Children 6 Months to < 12 Years https://clinicaltrials.gov/ct2/show/NCT05468736Nuevo estudio recién publicado, en fase de reclutamiento.Estimated Primary Completion Date  : | November 13, 2023Estimated Study Completion Date  : | September 8, 2025 
Ir a respuesta
Thonn 21/07/22 10:11
Ha respondido al tema Novavax (NVAX): Un Nuevo Comienzo
CDC Novavax COVID-19 Vaccination Operational Planning Guidehttps://www.cdc.gov/vaccines/covid-19/downloads/Novavax-COVID-19-Vaccination-Operational-Planning-Guide.pdf A limited number of doses of Novavax COVID-19 vaccine will be distributed and not all providers are expected to carry Novavax COVID-19 vaccine. There will be a limited supply of Novavax COVID-19 vaccine of approximately 3 million doses, which should be directed to providers with expected demand among unvaccinated patients. While jurisdictions and providers are encouraged to adopt strategies to minimize unnecessary wastage, they should not miss any opportunities to vaccinate every eligible person who requests a vaccination, even if it means puncturing a multidose vial to administer vaccine without having enough people available to receive each dose in the vial. A limited quantity of doses will be held and distributed based on need.Parece que, a diferencia de lo que hemos visto en el resto de países, donde se enviaban las vacunas independientemente de la cantidad que tenían sin inocular, en el caso de USA van a ser prudentes y harán los pedidos en función de la aceptación y la necesidad de vacunas.Siguiendo la encuesta que se mencionó en la conferencia del otro día, que decía que de los 26-34 millones de estadounidenses no vacunados, el 16% "probablemente" o "definitivamente" se vacunarian con una vacuna de proteínas como la de Novavax, eso supone entre 8.32 y 10.88 millones de dosis (2 dosis por persona, suponiendo que no se desperdicia ninguna). Entiendo que ese es el pedido mínimo que deberíamos esperar en el corto plazo, hasta tener más noticias de la aprobación como Booster.
Ir a respuesta
Thonn 20/07/22 20:50
Ha respondido al tema Novavax (NVAX): Un Nuevo Comienzo
https://www.reuters.com/business/healthcare-pharmaceuticals/eu-seals-deal-with-valneva-cut-volume-covid-vaccine-supplies-2022-07-20/EU drops nearly all of its order for Valneva COVID vaccine
Ir a respuesta
Thonn 20/07/22 17:44
Ha respondido al tema Novavax (NVAX): Un Nuevo Comienzo
 Novavax says U.S. FDA clears COVID vaccine doses for release https://www.reuters.com/business/healthcare-pharmaceuticals/novavax-says-us-fda-clears-covid-vaccine-doses-release-2022-07-19/
Ir a respuesta
Thonn 20/07/22 10:33
Ha respondido al tema Novavax (NVAX): Un Nuevo Comienzo
U.S. Centers for Disease Control and Prevention Endorses Advisory Committee on Immunization Practices’ Recommendation for Novavax COVID-19 Vaccine, AdjuvantedJul 19, 2022• U.S. CDC Advisory Committee unanimously recommended vaccination with Novavax COVID-19 Vaccine, Adjuvanted for individuals aged 18 and older earlier today• Novavax’ vaccine is the first protein-based vaccine to receive Emergency Use Authorization and CDC endorsement in the U.S.Today the U.S. Centers for Disease Control and Prevention (CDC) endorsed the Novavax COVID-19 Vaccine, Adjuvanted (NVX-CoV2373) for active immunization against SARS-CoV-2, following the Advisory Committee on Immunization Practices’ (ACIP) unanimous vote to recommend the vaccine as a two-dose primary series in individuals aged 18 and older. The CDC establishes its vaccine recommendations and schedules based on advice from ACIP.The recommendation follows the Emergency Use Authorization (EUA) granted by the U.S. Food and Drug Administration (FDA). The FDA has determined that the first vaccine lot has met all release specifications and is acceptable for use under EUA. Novavax expects to ship doses to the U.S. Government-designated distribution center in the coming days.Use of the Novavax COVID-19 Vaccine, Adjuvanted in the U.S.The Novavax COVID-19 Vaccine, Adjuvanted has not been approved or licensed by the US Food and Drug Administration (FDA), but has been authorized for emergency use by FDA, under an Emergency Use Authorization (EUA) to provide a two-dose primary series to individuals 18 years of age and older to prevent Coronavirus Disease 2019 (COVID-19).The emergency use of this product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of the medical product under Section 564(b)(1) of the FD&C Act unless the declaration is terminated or authorization revoked sooner.Authorized UseThe Novavax COVID-19 Vaccine, Adjuvanted is authorized for use under an Emergency Use Authorization (EUA) to provide a two-dose primary series for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals 18 years of age and older.https://ir.novavax.com/U-S-Centers-for-Disease-Control-and-Prevention-Endorses-Advisory-Committee-on-Immunization-Practices-Recommendation-for-Novavax-COVID-19-Vaccine,-Adjuvanted
Ir a respuesta